The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
Open accessAbstract
&NA; The renin‐angiotensin system (RAS) is undisputedly one of the most prominent endocrine (tissue‐to‐tissue), paracrine (cell‐to‐cell) and intracrine (intracellular/nuclear) vasoactive systems in the physiological regulation of neural, cardiovascular, blood pressure, and kidney function. The importance of the RAS in the development and pathogenesis of cardiovascular, hypertensive and kidney diseases has now been firmly established in clinical trials and practice using renin inhibitors, angiotensin‐converting enzyme (ACE) inhibitors, type 1 (AT1) angiotensin II (ANG II) receptor blockers (ARBs), or aldosterone receptor antagonists as major therapeutic drugs. The major mechanisms of actions for these RAS inhibitors or receptor blockers are mediated primarily by blocking the detrimental effects of the classic angiotensinogen/renin/ACE/ANG II/AT1/aldosterone axis. However, the RAS has expanded from this classic axis to include several other complex biochemical and physiological axes, which are derived from the metabolism of this classic axis. Currently, at least five axes of the RAS have been described, with each having its key substrate, enzyme, effector peptide, receptor, and/or downstream signaling pathways. These include the classic angiotensinogen/renin/ACE/ANG II/AT1 receptor, the ANG II/APA/ANG III/AT2/NO/cGMP, the ANG I/ANG II/ACE2/ANG (1–7)/Mas receptor, the prorenin/renin/prorenin receptor (PRR or Atp6ap2)/MAP kinases ERK1/2/V‐ATPase, and the ANG III/APN/ANG IV/IRAP/AT4 receptor axes. Since the roles and therapeutic implications of the classic angiotensinogen/renin/ACE/ANG II/AT1 receptor axis have been extensively reviewed, this article will focus primarily on reviewing the roles and therapeutic implications of the vasoprotective axes of the RAS in cardiovascular, hypertensive and kidney diseases. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
STUDIES ON EXPERIMENTAL HYPERTENSION
Goldblatt, H., Lynch, J., Hanzal, R. F., & Summerville, W. W. (1934) · Journal of Experimental Medicine · doi:10.1084/jem.59.3.347 · Cited by 2,142
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130
THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME
Skeggs, L. T., Kahn, J. R., & Shumway, N. P. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.3.295 · Cited by 1,032
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, M., Matsudat, Y., & lnagami, T. (1991) · Nature · doi:10.1038/351230a0 · Cited by 811
Tigerstedt, R., & Bergman, P. Q. (1898) · Skandinavisches Archiv Für Physiologie · doi:10.1111/j.1748-1716.1898.tb00272.x · Cited by 794
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A. D., & MacAllister, R. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67814-2 · Cited by 745
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742
Paracrine regulation of the renal microcirculation
Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison-Bernard, L. M., & Mitchell, K. D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.425 · Cited by 741
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Crowley, S. D., Gurley, S. B., Herrera, M. J., Ruiz, P., Griffiths, R., Kumar, A. P., Kim, H.-S., Smithies, O., Le, T. H., & Coffman, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605545103 · Cited by 714
Angiotensin II type 2 receptor mediates programmed cell death.
Yamada, T., Horiuchi, M., & Dzau, V. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.156 · Cited by 697
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz, W., Wiemer, G., Gohlke, P., Unger, T., & Schölkens, B. A. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06820-6 · Cited by 650
Male–female differences in fertility and blood pressure in ACE-deficient mice
Krege, J. H., John, S. W. M., Langenbach, L. L., Hodgin, J. B., Hagaman, J. R., Bachman, E. S., Jennette, J. C., O'Brien, D. A., & Smithies, O. (1995) · Nature · doi:10.1038/375146a0 · Cited by 644
Genetic control of blood pressure and the angiotensinogen locus.
Kim, H. S., Krege, J. H., Kluckman, K. D., Hagaman, J. R., Hodgin, J. B., Best, C. F., Jennette, J. C., Coffman, T. M., Maeda, N., & Smithies, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2735 · Cited by 642
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7886 · Cited by 561
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I., & Batlle, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050423 · Cited by 485
Young, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
Albiston, A. L., McDowall, S. G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 461
Discovery and Characterization of Alamandine: A Novel Component of the Renin–Angiotensin System
Lautner, R. Q., Villela, D. C., Fraga-Silva, R. A., Silva, N., Verano-Braga, T., Costa-Fraga, F., Jankowski, J., Jankowski, V., Sousa, F., Alzamora, A., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301077 · Cited by 438
Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.
Seikaly, M. G., Arant, B. S., & Seney, F. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114846 · Cited by 425
Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., & Lazartigues, E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00292.2006 · Cited by 406
The mas oncogene encodes an angiotensin receptor
Jackson, T. R., Blair, L. A. C., Marshall, J., Goedert, M., & Hanley, M. R. (1988) · Nature · doi:10.1038/335437a0 · Cited by 395
Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J., & Krähenbühl, S. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0072-7 · Cited by 361
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
Niimura, F., Labosky, P. A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A. J., Fogo, A., & Inagami, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118366 · Cited by 337
Tsuchida, S., Matsusaka, T., Chen, X., Okubo, S., Niimura, F., Nishimura, H., Fogo, A., Utsunomiya, H., Inagami, T., & Ichikawa, I. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1899 · Cited by 335
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci16980 · Cited by 334
Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist
Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlén, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049715t · Cited by 330
Siragy, H. M., Inagami, T., Ichiki, T., & Carey, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6506 · Cited by 328
Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Oliverio, M. I., Kim, H.-S., Ito, M., Le, T., Audoly, L., Best, C. F., Hiller, S., Kluckman, K., Maeda, N., Smithies, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15496 · Cited by 316
THE PREPARATION, PURIFICATION, AND AMINO ACID SEQUENCE OF A POLYPEPTIDE RENIN SUBSTRATE
Skeggs, L. T., Kahn, J. R., Lentz, K., & Shumway, N. P. (1957) · The Journal of Experimental Medicine · doi:10.1084/jem.106.3.439 · Cited by 316
Siragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Wysocki, J., Ye, M., Rodriguez, E., González-Pacheco, F. R., Barrios, C., Evora, K., Schuster, M., Loibner, H., Brosnihan, K. B., Ferrario, C. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.138420 · Cited by 300
Ichihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2001) · Circulation · doi:10.1161/01.cir.104.3.346 · Cited by 299
CHARACTERIZATION OF A DIPEPTIDE HYDROLASE (KININASE II: ANGIOTENSIN I CONVERTING ENZYME)
YANG, H. Y. T., ERDÖS, E. O., & LEVIN, Y. (1971) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28878-4 · Cited by 295
Under pressure: the search for the essential mechanisms of hypertension
Coffman, T. M. (2011) · Nature Medicine · doi:10.1038/nm.2541 · Cited by 284
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280
Angiotensin II and the Heart: On the Intracrine Renin-Angiotensin System
De Mello, W. C., & Danser, A. H. J. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1183 · Cited by 279
Cloning and expression of a novel angiotensin II receptor subtype.
Sandberg, K., Ji, H., Clark, A. J., Shapira, H., & Catt, K. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50109-0 · Cited by 274
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
Esther, C. R., Marino, E. M., Howard, T. E., Machaud, A., Corvol, P., Capecchi, M. R., & Bernstein, K. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119419 · Cited by 272
Hernández Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A. S., Castellano, R. K., Lampkins, A. J., Gubala, V., Ostrov, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108944 · Cited by 271
Angiotensin-Converting Enzyme II in the Heart and the Kidney
Danilczyk, U., & Penninger, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000205761.22353.5f · Cited by 269
Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W., & Herzenberg, A. M. (2008) · Kidney International · doi:10.1038/ki.2008.497 · Cited by 252
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
Campbell, D. J., Lawrence, A. C., Towrie, A., Kladis, A., & Valentijn, A. J. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.763 · Cited by 242
Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241
Cloning and sequence analysis of cDNA for rat angiotensinogen.
Ohkubo, H., Kageyama, R., Ujihara, M., Hirose, T., Inayama, S., & Nakanishi, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2196 · Cited by 239
Renal ACE2 expression in human kidney disease
Lely, A., Hamming, I., van Goor, H., & Navis, G. (2004) · The Journal of Pathology · doi:10.1002/path.1670 · Cited by 239
What?s new in the renin-angiotensin system?: The angiotensin IV/AT4 receptor
Chai, S. Y., Fernando, R., Peck, G., Ye, S. Y., Mendelsohn, F. A. O., Jenkins, T. A., & Albiston, A. L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4246-1 · Cited by 237
Senbonmatsu, T., Ichihara, S., Price, E., Gaffney, F. A., & Inagami, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10037 · Cited by 230
Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor
Furuta, H., Guo, D.-F., & Inagami, T. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91600-u · Cited by 220
The regulation of aldosterone synthase expression
Bassett, M. H., White, P. C., & Rainey, W. E. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.011 · Cited by 220
Intratubular Renin-Angiotensin System in Hypertension
Navar, L. G., Kobori, H., Prieto, M. C., & Gonzalez-Villalobos, R. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163519 · Cited by 219
Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls
Mizuiri, S., Hemmi, H., Arita, M., Ohashi, Y., Tanaka, Y., Miyagi, M., Sakai, K., Ishikawa, Y., Shibuya, K., Hase, H., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.022 · Cited by 218
Rompe, F., Artuc, M., Hallberg, A., Alterman, M., Ströder, K., Thöne-Reineke, C., Reichenbach, A., Schacherl, J., Dahlöf, B., Bader, M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147843 · Cited by 208
Walters, P. E., Gaspari, T. A., & Widdop, R. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000160325.59323.b8 · Cited by 206
Chappell, M. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076216 · Cited by 206
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Díez-Freire, C., Vázquez, J., Correa de Adjounian, M. F., Ferrari, M. F. R., Yuan, L., Silver, X., Torres, R., & Raizada, M. K. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00312.2005 · Cited by 200
O’Brien, E., Barton, J., Nussberger, J., Mulcahy, D., Jensen, C., Dicker, P., & Stanton, A. (2007) · Hypertension · doi:10.1161/01.hyp.0000253780.36691.4f · Cited by 199
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000037979.53963.8f · Cited by 199
Mecca, A. P., Regenhardt, R. W., O’Connor, T. E., Joseph, J. P., Raizada, M. K., Katovich, M. J., & Sumners, C. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.058578 · Cited by 197
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma
Jankowski, V., Vanholder, R., van der Giet, M., Tölle, M., Karadogan, S., Gobom, J., Furkert, J., Oksche, A., Krause, E., Anh Tran, T. N., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000253889.09765.5f · Cited by 197
Sustained Long Term Potentiation and Anxiety in Mice Lacking theMas Protooncogene
Walther, T., Balschun, D., Voigt, J.-P., Fink, H., Zuschratter, W., Birchmeier, C., Ganten, D., & Bader, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11867 · Cited by 196
Pharmacology of diminazene: a review
Peregrine, A. S., & Mamman, M. (1993) · Acta Tropica · doi:10.1016/0001-706x(93)90092-p · Cited by 191
Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice
Xu, P., Costa-Goncalves, A. C., Todiras, M., Rabelo, L. A., Sampaio, W. O., Moura, M. M., Sousa Santos, S., Luft, F. C., Bader, M., Gross, V., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102764 · Cited by 191
Feng, Y., Xia, H., Cai, Y., Halabi, C. M., Becker, L. K., Santos, R. A. S., Speth, R. C., Sigmund, C. D., & Lazartigues, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.208645 · Cited by 190
Rentzsch, B., Todiras, M., Iliescu, R., Popova, E., Campos, L. A., Oliveira, M. L., Baltatu, O. C., Santos, R. A., & Bader, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114322 · Cited by 187
Santos, R. A. S., Ferreira, A. J., Nadu, A. P., Braga, A. N. G., de Almeida, A. P., Campagnole-Santos, M. J., Baltatu, O., Iliescu, R., Reudelhuber, T. L., & Bader, M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00227.2003 · Cited by 187
Angiotensin-(1-7): a new hormone of the angiotensin system.
Ferrario, C. M., Brosnihan, K. B., Diz, D. I., Jaiswal, N., Khosla, M. C., Milsted, A., & Tallant, E. A. (1991) · Hypertension · doi:10.1161/01.hyp.18.5_suppl.iii126 · Cited by 182
Balakumar, P., & Jagadeesh, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.011 · Cited by 182
Yamazato, M., Yamazato, Y., Sun, C., Diez-Freire, C., & Raizada, M. K. (2007) · Hypertension · doi:10.1161/01.hyp.0000259942.38108.20 · Cited by 180
Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.513 · Cited by 180
Mas and Its Related G Protein–Coupled Receptors, Mrgprs
Bader, M., Alenina, N., Andrade-Navarro, M. A., & Santos, R. A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008136 · Cited by 179
Zhuo, J. L., & Li, X. C. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110061 · Cited by 179
Self-citationAngiotensin II Receptors and Functional Correlates
Timmermans, P. B. M. W. M., Benfield, P., Chiu, A. T., Herblin, W. F., Wong, P. C., & Smith, R. D. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.12.221s · Cited by 177
Lévy, B. I. (2004) · Circulation · doi:10.1161/01.cir.0000096609.73772.c5 · Cited by 176
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175
da Silveira, K. D., Coelho, F. M., Vieira, A. T., Sachs, D., Barroso, L. C., Costa, V. V., Bretas, T. L. B., Bader, M., de Sousa, L. P., da Silva, T. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000314 · Cited by 170
Guan, S., Fox, J., Mitchell, K. D., & Navar, L. G. (1992) · Hypertension · doi:10.1161/01.hyp.20.6.763 · Cited by 169
The Kallikrein‐Kinin System as a Regulator of Cardiovascular and Renal Function
Rhaleb, N., Yang, X., & Carretero, O. A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100053 · Cited by 168
Shenoy, V., Gjymishka, A., Jarajapu, Y. P., Qi, Y., Afzal, A., Rigatto, K., Ferreira, A. J., Fraga-Silva, R. A., Kearns, P., Douglas, J. Y., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0880oc · Cited by 167
Rehman, A., Leibowitz, A., Yamamoto, N., Rautureau, Y., Paradis, P., & Schiffrin, E. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180158 · Cited by 167
Angiotensin-(1–7) prevents diabetes-induced cardiovascular dysfunction
Benter, I. F., Yousif, M. H. M., Cojocel, C., Al-Maghrebi, M., & Diz, D. I. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2006 · Cited by 167
Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla, T., Baukal, A. J., Eng, S., & Catt, K. J. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12929-5 · Cited by 165
Lew, R. A., Mustafa, T., Ye, S., McDowall, S. G., Chai, S. Y., & Albiston, A. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01852.x · Cited by 163
Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
Dias-Peixoto, M. F., Santos, R. A. S., Gomes, E. R. M., Alves, M. N. M., Almeida, P. W. M., Greco, L., Rosa, M., Fauler, B., Bader, M., Alenina, N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114280 · Cited by 163
The ANG-(1–7)/ACE2/mas axis in the regulation of nephron function
Ferrario, C. M., & Varagić, J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2010 · Cited by 151
Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
Matavelli, L. C., Huang, J., & Siragy, H. M. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.164202 · Cited by 150
Pharmacology and Signaling of MAS-Related G Protein–Coupled Receptors
Solinski, H. J., Gudermann, T. W., & Breit, A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008425 · Cited by 148
Barber, M., Sampey, D. B., & Widdop, R. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.5.1112 · Cited by 148
Padia, S. H., Howell, N. L., Siragy, H. M., & Carey, R. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000196950.48596.21 · Cited by 146
Unraveling the Mystery of Goldblatt Hypertension
Navar, L. G., Zou, L., Thun, A. M. V., Wang, C. T., Imig, J. D., & Mitchell, K. D. (1998) · Physiology · doi:10.1152/physiologyonline.1998.13.4.170 · Cited by 146
Feng, Y., Yue, X., Xia, H., Bindom, S. M., Hickman, P. J., Filipeanu, C. M., Wu, G., & Lazartigues, E. D. (2008) · Circulation Research · doi:10.1161/circresaha.107.169110 · Cited by 141
Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion
Thun, A. M. V., Vari, R. C., El-Dahr, S. S., & Navar, L. G. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.1.f120 · Cited by 141
Ahmad, S., & Ward, P. E. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)19965-5 · Cited by 134
Tetzner, A., Gebolys, K., Meinert, C., Klein, S., Uhlich, A., Trebicka, J., Villacañas, Ó., & Walther, T. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07572 · Cited by 134
Cao, Z., Kelly, D. J., Cox, A. J., CASLEY, D. J., Forbes, J. M., Martinello, P., Dean, R. G., Gilbert, R. E., & Cooper, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00427.x · Cited by 133
Skiba, D. S., Nosalski, R., Mikolajczyk, T. P., Siedliński, M., Rios, F. J. O., Montezano, A. C. I., Jawień, J., Olszanecki, R., Korbut, R., Cześnikiewicz‐Guzik, M., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13685 · Cited by 133
Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors
Zhuo, J. L., Moeller, I., Jenkins, T. A., Chai, S. Y., Allen, A. M., Ohishi, M., & Mendelsohn, F. A. O. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00026 · Cited by 131
Self-citationQi, Y., Zhang, J., Cole‐Jeffrey, C. T., Shenoy, V., Espejo, A., Hanna, M., Song, C., Pepine, C. J., Katovich, M. J., & Raizada, M. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01337 · Cited by 131
Self-citationCloning of cDNA and Analysis of the Gene for Mouse Angiotensin II Type 2 Receptor
Nakajima, M., Mukoyama, M., Pratt, R. E., Horiuchi, M., & Dzau, V. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2492 · Cited by 129
Nonclassical Renin‐Angiotensin System and Renal Function
Chappell, M. C. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120002 · Cited by 128
Lemos, V. S., Silva, D. M. R., Walther, T., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000175237.41573.63 · Cited by 128
Ferreira, A. J., Jacoby, B. A., Araújo, C. A. A., Macedo, F. A. F. F., Silva, G. A. B., Almeida, A. P., Caliari, M. V., & Santos, R. A. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00828.2006 · Cited by 127
Liu, C. X., Hu, Q., Wang, Y., Zhang, W., Ma, Z. Y., Feng, J. B., Wang, R., Wang, X. P., Dong, B., Gao, F., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00111 · Cited by 127
Angiotensin-II, the Brain, and Hypertension: An Update
Young, C. N., & Davisson, R. L. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.03624 · Cited by 123
Benndorf, R. A., Böger, R. H., Ergün, S., Steenpaß, A., & Wieland, T. (2003) · Circulation Research · doi:10.1161/01.res.0000088358.99466.04 · Cited by 123
Young, D., O’Neill, K. E., Jessell, T. M., & Wigler, M. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5339 · Cited by 122
AT2Receptor Activation Induces Natriuresis and Lowers Blood Pressure
Kemp, B. A., Howell, N. L., Gildea, J. J., Keller, S. R., Padia, S. H., & Carey, R. M. (2014) · Circulation Research · doi:10.1161/circresaha.115.304110 · Cited by 118
Zhuo, J. L., Ferrão, F. M., Zheng, Y., & Li, X. C. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00166 · Cited by 117
Self-citationNadarajah, R., Milagres, R., Dilauro, M., Gutsol, A. A., Xiao, F., Zimpelmann, J., Kennedy, C., Wysocki, J. A., BATLLE, D. C., & Burns, K. D. (2012) · Kidney International · doi:10.1038/ki.2012.83 · Cited by 116
Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice
Mentzel, S., Dijkman, H. B., Van Son, J. P., Koene, R. A., & Assmann, K. J. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.5.8627002 · Cited by 108
Faria-Silva, R., Duarte, F. V., & Santos, R. A. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000174594.17052.33 · Cited by 108
Villela, D. C., Passos-Silva, D. G., & Santos, R. A. S. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000441052.44406.92 · Cited by 108
Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
Villela, D. C., Leonhardt, J., Patel, N., Joseph, J. P., Kirsch, S., Hallberg, A., Unger, T., Bäder, M., Santos, R. A. S., Sumners, C., et al. (2014) · Clinical Science · doi:10.1042/cs20130515 · Cited by 102
Molecular Cloning and Expression of the Gene Encoding Human Angiotensin II Type 2 Receptor
Tsuzuki, S., Ichiki, T., Nakakubo, H., Kitami, Y., Guo, D., Shirai, H., & Inagami, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1613 · Cited by 100
Angiotensin III: A physiological relevant peptide of the renin angiotensin system
Yugandhar, V. G., & Clark, M. A. (2013) · Peptides · doi:10.1016/j.peptides.2013.04.014 · Cited by 96
Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications
Carey, R. M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02076-3 · Cited by 94
Steckelings, U. M., Paulis, L., Namsolleck, P., & Unger, T. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328350261b · Cited by 91
Kemp, B. A., Bell, J. F., Rottkamp, D. M., Howell, N. L., Shao, W., Navar, L. G., Padia, S. H., & Carey, R. M. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191403 · Cited by 89
Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes
Velez, J. C. Q., Bland, A. M., Arthur, J. M., Raymond, J. R., & Janech, M. G. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00050.2007 · Cited by 88
Zhuo, J. L., Song, K., Abdelrahman, A. M., & Mendelsohn, F. A. O. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02555.x · Cited by 86
Self-citationNuclear angiotensin-(1–7) receptor is functionally coupled to the formation of nitric oxide
Gwathmey, T. M., Westwood, B. M., Pirro, N. T., Tang, L., Rose, J. C., Diz, D. I., & Chappell, M. C. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2010 · Cited by 83
Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension
Pang, X., Shimizu, A., Kurita, S., Zankov, D. P., Takeuchi, K., Yasuda‒Yamahara, M., Kume, S., Ishida, T., & Ogita, H. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07357 · Cited by 83
AT2 receptor‐mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR
Li, X. C., & Widdop, R. E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705838 · Cited by 82
Self-citationAli, Q., Wu, Y., & Hussain, T. (2013) · Kidney International · doi:10.1038/ki.2013.193 · Cited by 81
Healy, D. P., & Wilk, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90997-2 · Cited by 80
Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?
Reudelhuber, T. L., Bernstein, K. E., & Delafontaine, P. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.075085 · Cited by 80
Padia, S. H., Kemp, B. A., Howell, N. L., Siragy, H. M., Fournié‐Zaluski, M., Roques, B. P., & Carey, R. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000254833.85106.4d · Cited by 79
Angiotensin II Receptor Subtypes in the Human Renal Cortex and Renal Cell Carcinoma
Goldfarb, D. A., Diz, D. I., Tubbs, R. R., Ferrario, C. M., & Novick, A. C. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)34918-2 · Cited by 79
Localization of angiotensin AT1 and AT2 receptors.
Allen, A. M., Zhuo, J. L., & Mendelsohn, F. A. O. (1999) · PubMed · Cited by 78
Self-citationIn vitro Autoradiography Reveals Predominantly AT1 Angiotensin II Receptors in Rat Kidney
Zhuo, J. L., Song, K., Harris, P. J. F., & Mendelsohn, F. A. O. (1992) · Kidney & Blood Pressure Research · doi:10.1159/000173458 · Cited by 75
Self-citationSouza, A. M. D., Lopes, A. G., Pizzino, C. P., Fossari, R. N., Miguel, N. C. O., Cardozo, F. P., Abi-Abib, R. D. C., Fernandes, M. S., Santos, D. P. A., & Caruso‐Neves, C. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.005 · Cited by 74
AT2 Receptors: Potential Therapeutic Targets for Hypertension
Carey, R. M. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw121 · Cited by 73
Sabuhi, R., Ali, Q., Asghar, M., Al-Zamily, N. R. H., & Hussain, T. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00616.2010 · Cited by 71
Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene
Walther, T., Wessel, N., Kang, N., Sander, A., Tschöpe, C., Malberg, H., Bäder, M., & Voss, A. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000100001 · Cited by 69
Santos, G. A. B., Sampaio, W. O., Reudelhuber, T. L., Bäder, M., Campagnole‐Santos, M. J., & Santos, R. A. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01245.2006 · Cited by 69
Angiotensin (1-7) and Alamandine: Similarities and differences
Qaradakhi, T., Apostolopoulos, V., & Zulli, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.025 · Cited by 69
Clinical Relevance of Local Renin Angiotensin Systems
Campbell, D. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00113 · Cited by 66
Dipeptidyl peptidase III is a zinc metallo-exopeptidase: Molecular cloning and expression
Fukasawa, K., FUKASAWA, M. K., Kanai, M., Fujii, S., Hirose, J., & Harada, M. (1998) · Biochemical Journal · doi:10.1042/bj3290275 · Cited by 64
Padia, S. H., Kemp, B. A., Howell, N. L., Gildea, J. J., Keller, S. R., & Carey, R. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.124198 · Cited by 63
Ambroz, C., Clark, A. J. L., & Catt, K. J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90248-v · Cited by 61
Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
Zhuo, J. L., Dean, R. G., MacGregor, D. P., Alcorn, D., & Mendelsohn, F. A. O. (1996) · PubMed · Cited by 59
Self-citationUnger, T., & Dahlöf, B. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309347792 · Cited by 59
Intrarenal Angiotensin-Converting Enzyme Induces Hypertension in Response to Angiotensin I Infusion
González-Villalobos, R. A., Billet, S., Kim, C., Satou, R., Fuchs, S., Bernstein, K. E., & Navar, L. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060624 · Cited by 59
Sampson, A. K., Irvine, J. C., Shihata, W., Dragoljevic, D., Lumsden, N. G., Huet, O., Barnes, T. A., Unger, T., Steckelings, U. M., Jennings, G., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13063 · Cited by 58
Localization and properties of angiotensin II receptors in rat kidney.
Zhuo, J. L., Alcorn, D., Harris, P. J. F., & Mendelsohn, F. A. O. (1993) · PubMed · Cited by 56
Self-citationHypertension and Angiotensin II Hypersensitivity in Aminopeptidase A—deficient Mice
Mitsui, T., Nomura, S., Okada, M., Ohno, Y., Kobayashi, H., Nakashima, Y., Murata, Y., Takeuchi, M., Kuno, N., Nagasaka, T., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402108 · Cited by 56
Update on angiotensin AT2 receptors
Carey, R. M. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000304 · Cited by 54
Hakam, A. C., & Hussain, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000220112.91724.fc · Cited by 49
Angioprotectin: an angiotensin II‐like peptide causing vasodilatory effects
Jankowski, V., Tölle, M., Santos, R. A. S., Günthner, T., Krause, E., Beyermann, M., Welker, P., Bäder, M., Pinheiro, S. V. B., Sampaio, W. O., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-185470 · Cited by 48
Diminazene aceturate improves autonomic modulation in pulmonary hypertension
Rigatto, K., Casali, K. R., Shenoy, V., Katovich, M. J., & Raizada, M. K. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.017 · Cited by 47
Zhuo, J. L., Dean, R. G., MacGregor, D. P., Alcorn, D., & Mendelsohn, F. A. O. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb03077.x · Cited by 47
Self-citationSimultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man
Campbell, D. J., & Kladis, A. (1990) · Journal of Hypertension · doi:10.1097/00004872-199002000-00011 · Cited by 46
Cruz‐Diaz, N., Wilson, B. A., Pirro, N. T., Brosnihan, K. B., Marshall, A. C., & Chappell, M. C. (2016) · Peptides · doi:10.1016/j.peptides.2016.06.005 · Cited by 46
Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia
Iwanami, J., Mogi, M., Tsukuda, K., Wang, X., Nakaoka, H., Kan‐no, H., Chisaka, T., Bai, H., Shan, B., Kukida, M., et al. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.01.010 · Cited by 45
Angiotensin converting enzyme 2 and diminazene
Velkoska, E., Patel, S. K., & Burrell, L. M. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000254 · Cited by 45
Zhang, T., Li, Z., Dang, H., Chen, R., Liaw, C. W., Tran, T.-A., Boatman, P. D., Connolly, D. T., & Adams, J. W. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2011 · Cited by 44
T and B Cell Development in BP-1/6C3/Aminopeptidase A-Deficient Mice
Lin, Q., Taniuchi, I., Kitamura, D., Wang, J., Kearney, J. F., Watanabe, T., & Cooper, M. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4681 · Cited by 42
Xu, J., Carretero, O. A., Lin, C.-X., Cavasin, M. A., Shesely, E. G., Yang, J., Reudelhuber, T. L., & Yang, X.-P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00379.2007 · Cited by 42
Mário, É. G., Santos, S. H. S., Ferreira, A. V. M., Bäder, M., Santos, R. A. S., & Botion, L. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.014 · Cited by 42
Kidney Aminopeptidase A and Hypertension, Part II: Effects of Angiotensin II
Song, L., & Healy, D. P. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.746 · Cited by 42
Patel, S. N., Ali, Q., & Hussain, T. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06881 · Cited by 42
The distribution of angiotensin II receptors
Zhuo, J. L. (1995) · Cited by 42
Self-citationImpact of the AT2 Receptor Agonist C21 on Blood Pressure and Beyond
Foulquier, S., Steckelings, U. M., & Unger, T. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0291-6 · Cited by 41
AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress
Ma, Y., Huang, H., Jiang, J., Wu, L., Lin, C., Tang, A., Dai, G., He, J., & Chen, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.050 · Cited by 38
AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice.
Toton-Zuranska, J., Gajda, M., Pyka‐Fościak, G., et al. (2010) · PubMed · Cited by 38
Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
Ferreira, A. J., Pinheiro, S. V. B., Castro, C. H., et al. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.06.005 · Cited by 37
Brouwers, S., Smolders, I. J., Massie, A., & Dupont, A. G. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.00762 · Cited by 37
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis
Wysocki, J. A., Ye, M., & BATLLE, D. C. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv054 · Cited by 37
Bernstein, K. E. (2002) · Nature · doi:10.1038/417799a · Cited by 36
Monnot, C., Weber, V., Stinnakre, J., Bihoreau, C., Teutsch, B., Corvol, P. L., & Clauser, É. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1477 · Cited by 33
A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
Matavelli, L. C., Zatz, R., & Siragy, H. M. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000207 · Cited by 32
Olkowicz, M., Radulska, A., Suraj, J., Kij, A., Walczak, M., Chłopicki, S., & Smolenski, R. T. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.03.012 · Cited by 29
Breitling, S., Krauszman, A., Parihar, R., Walther, T., Friedberg, M. K., & Kuebler, W. M. (2015) · Pulmonary Circulation · doi:10.1086/683696 · Cited by 29
Hekmat, A. S., Javanmardi, K., Kouhpayeh, S. A., Baharamali, E., & Farjam, M. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0958 · Cited by 29
Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis
Romero, D. G., Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00098.2010 · Cited by 25
The genetic deletion of Mas abolishes salt induced hypertension in mice
Heringer‐Walther, S., Gembardt, F., Perschel, F. H., Katz, N. R., Schultheiss, H., & Walther, T. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.025 · Cited by 24
Jancovski, N., Bassi, J. K., Carter, D. A., Choong, Y., Connelly, A. A., Nguyen, T.-P., Chen, D., Lukoshkova, E. V., Menuet, C., Head, G. A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01474 · Cited by 23
The Discovery of the ACE2 Gene
Marian, A. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.301271 · Cited by 22
Cited by
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007621 · Cited by 1,428
RetractedDiabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Singh, A. K., Gupta, R., Ghosh, A., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.004 · Cited by 893
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Deutsch, G., Lacy, J. M., Williams, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31305-2 · Cited by 822
Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.571416 · Cited by 476
Metadata
- Authors
- Li, X. C., Zhang, J., & Zhuo, J. L.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 125
- Issue
- Pt A
- Pages
- 21-38
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2625441704
- Cited by
- 435
- References
- 203
- FWCI
- 37.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.